Cargando…
Breast Cancer Screening and Axillary Adenopathy in the Era of COVID-19 Vaccination
A 50-year-old woman with persistent axillary lymphadenopathy 17 weeks after COVID-19 vaccination was ultimately diagnosed with biopsy-proven benign reactive lymphadenopathy. In contrast, a 60-year-old woman with axillary lymphadenopathy and concurrent suspicious breast findings 9 weeks after COVID-1...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Radiological Society of North America
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9580051/ https://www.ncbi.nlm.nih.gov/pubmed/36219117 http://dx.doi.org/10.1148/radiol.222040 |